fabG1 Resolved · high auto-curated

H37Rv Rv1483 · MTBC0 mtbc0_001586 · 247 aa · 1683245–1683988 MTBC0 (+) · RefSeq NP_215999.1

Genomic neighbourhood (genome browser)

Open in full genome browser →

This gene (outlined) in its genomic context; arrows are neighbouring genes coloured by verdict. Click any gene to navigate. Pan and zoom in the full browser.

Annotation: from legacy to revised

Legacy (H37Rv / Mycobrowser)3-oxoacyl-ACP reductase FabG
MTBC0 PGAP re-annotation3-oxoacyl-ACP reductase FabG1
Revised (this work)3-oxoacyl-ACP reductase FabG1. Pfam: adh_short (PF00106.32), Epimerase (PF01370.28), adh_short_C2 (PF13561.13), KR (PF08659.17).
Functional category (TubercuList)lipid metabolism

Auto-curated: this verdict and function were generated by rules from PGAP + Pfam + Foldseek and have not been hand-reviewed.

In the literature (TB corpus sweep) 54 publications

54 TB publications mention this gene. 54 publications discuss this gene. Queried separately, 53 records carry a M. tuberculosis context and 3 a non-TB mycobacterial context (species named in the 3-record verified sample: M. smegmatis (2), M. leprae (1)). The three counts come from three distinct PubMed queries (each with its own context filter), so they neither partition the total nor need to add up to it.

5 of 54: the most recently indexed records of the curated sweep at its date, not necessarily the most recent papers on this gene — the exhaustive list below is later and broader and may hold newer ones.
PublicationDate
A cartridge-based assay for improved detection of multidrug-resistant Mycobacterium tuberculosis directly from sputum. doi:10.1128/jcm.01100-25 2026
Multicentre field evaluation of Xpert MTB/XDR in sub-Saharan Africa. doi:10.1183/23120541.00427-2025 2026
Genomic characterization of XDR Mycobacterium tuberculosis isolates in Argentina (2006-2015). doi:10.1186/s12879-025-11913-3 2025
Surveillance and analysis of drug resistance and drug resistance levels in multidrug resistant tuberculosis on the tropical islands of China. doi:10.1186/s12879-025-11312-8 2025
Lineage identification and mutation profile of Mycobacterium tuberculosis: A study from National Reference Laboratory, India. doi:10.1016/j.ijmmb.2025.100925 2025
56 records returned by the alias sweep (a separate sweep from the 54 above; both are shown, neither is exhaustive)

Searched as: Rv1483, fabG1, Mb1519, ML1807c, MMAR_2289, MSMEG_3150, MAB_2723c — each in conjunction with a mycobacterial context term. Swept 2026-09-07.

PublicationJournalYear
Mixed-strain infection and heteroresistance in drug-resistant tuberculosis: insights from a whole-genome sequencing pilot. doi:10.3389/fepid.2026.1813571 Front Epidemiol 2026
Melting temperature signatures reveal occasional misclassification of low-level isoniazid resistance by Xpert MTB/XDR. doi:10.1128/spectrum.00713-26 Microbiol Spectr 2026
A cartridge-based assay for improved detection of multidrug-resistant Mycobacterium tuberculosis directly from sputum. doi:10.1128/jcm.01100-25 J Clin Microbiol 2026
Multicentre field evaluation of Xpert MTB/XDR in sub-Saharan Africa. doi:10.1183/23120541.00427-2025 ERJ Open Res 2026
Identifying potent inhibitors for Mycobacterium tuberculosis MabA (FabG1). doi:10.1007/s11030-025-11205-7 names it Mol Divers 2026
Genomic characterization of XDR Mycobacterium tuberculosis isolates in Argentina (2006-2015). doi:10.1186/s12879-025-11913-3 BMC Infect Dis 2025
Surveillance and analysis of drug resistance and drug resistance levels in multidrug resistant tuberculosis on the tropical islands of China. doi:10.1186/s12879-025-11312-8 BMC Infect Dis 2025
Lineage identification and mutation profile of Mycobacterium tuberculosis: A study from National Reference Laboratory, India. doi:10.1016/j.ijmmb.2025.100925 Indian J Med Microbiol 2025
Unearthing novel mutations and genetic variation in drug sensitive and resistant isolates of Mycobacterium tuberculosis through whole genome sequencing: A study from eastern Uttar Pradesh, India. doi:10.1016/j.ijmmb.2025.100895 Indian J Med Microbiol 2025
Genetic diversity and transmission pattern of multidrug-resistant tuberculosis based on whole-genome sequencing in Wuhan, China. doi:10.3389/fpubh.2025.1442987 Front Public Health 2025
Characterization of isoniazid resistance and genetic mutations in isoniazid-resistant and rifampicin-susceptible Mycobacterium tuberculosis in China. doi:10.1016/j.imj.2024.100129 Infect Med (Beijing) 2024
Drug-Resistant Profiles and Genetic Diversity of Mycobacterium Tuberculosis Revealed by Whole-Genome Sequencing in Hinggan League of Inner Mongolia, China. doi:10.2147/IDR.S466197 Infect Drug Resist 2024
Dual-centre evaluation of the FluoroType MTBDR version 2 assay for detection of Mycobacterium tuberculosis complex and resistance-conferring mutations in pulmonary and extrapulmonary samples from Denmark, Germany and Sierra Leone. doi:10.1016/j.cmi.2024.04.006 Clin Microbiol Infect 2024
Co-resistance to isoniazid and second-line anti-tuberculosis drugs in isoniazid-resistant tuberculosis at a tertiary care hospital in Thailand. doi:10.1128/spectrum.03462-23 Microbiol Spectr 2024
Role of the first WHO mutation catalogue in the diagnosis of antibiotic resistance in Mycobacterium tuberculosis in the Valencia Region, Spain: a retrospective genomic analysis. doi:10.1016/S2666-5247(23)00252-5 Lancet Microbe 2024
Whole genome sequencing of drug-resistant Mycobacterium tuberculosis isolates in Victoria, Australia. doi:10.1016/j.ijid.2023.11.010 Int J Infect Dis 2024
In vitro modeling of isoniazid resistance mechanisms in Mycobacterium tuberculosis H37Rv. doi:10.3389/fmicb.2023.1171861 Front Microbiol 2023
Whole-genome sequencing reveals genotypic resistance in phenotypically susceptible Mycobacterium tuberculosis clinical isolates. doi:10.4103/ijmy.ijmy_101_23 Int J Mycobacteriol 2023
Emergence and evolution of drug-resistant Mycobacterium tuberculosis in eastern China: A six-year prospective study. doi:10.1016/j.ygeno.2023.110640 Genomics 2023
Exploring the Antitubercular Activity of Anthranilic Acid Derivatives: From MabA (FabG1) Inhibition to Intrabacterial Acidification. doi:10.3390/ph16030335 names it Pharmaceuticals (Basel) 2023
Whole-genome sequencing-based analyses of drug-resistant Mycobacterium tuberculosis from Taiwan. doi:10.1038/s41598-023-29652-3 Sci Rep 2023
Identification of potential inhibitor molecule against MabA protein of Mycobacterium leprae by integrated in silico approach. doi:10.1080/07391102.2022.2160818 J Biomol Struct Dyn 2023
Large-scale genomic analysis of Mycobacterium tuberculosis reveals extent of target and compensatory mutations linked to multi-drug resistant tuberculosis. doi:10.1038/s41598-023-27516-4 Sci Rep 2023
Genetic mutations underlying isoniazid-resistant Mycobacterium tuberculosis in Khyber Pakhtunkhwa, Pakistan. doi:10.1016/j.tube.2022.102286 Tuberculosis (Edinb) 2023
Prevalence and genetic basis of first-line drug resistance of Mycobacterium tuberculosis in Ca Mau, Vietnam. doi:10.1183/23120541.00122-2022 ERJ Open Res 2022
Whole-Genome Sequencing for Resistance Level Prediction in Multidrug-Resistant Tuberculosis. doi:10.1128/spectrum.02714-21 Microbiol Spectr 2022
Molecular Determinants of Ethionamide Resistance in Clinical Isolates of Mycobacterium tuberculosis. doi:10.3390/antibiotics11020133 Antibiotics (Basel) 2022
Whole-genome sequencing for surveillance of tuberculosis drug resistance and determination of resistance level in China. doi:10.1016/j.cmi.2021.09.014 Clin Microbiol Infect 2022
The whole-genome sequencing in predicting Mycobacterium tuberculosis drug susceptibility and resistance in Papua, Indonesia. doi:10.1186/s12864-021-08139-3 BMC Genomics 2021
Systematic Review of Mutations Associated with Isoniazid Resistance Points to Continuing Evolution and Subsequent Evasion of Molecular Detection, and Potential for Emergence of Multidrug Resistance in Clinical Strains of Mycobacterium tuberculosis. doi:10.1128/AAC.02091-20 Antimicrob Agents Chemother 2021
Identifying isoniazid resistance markers to guide inclusion of high-dose isoniazid in tuberculosis treatment regimens. doi:10.1016/j.cmi.2020.07.004 Clin Microbiol Infect 2020
Discovery of the first Mycobacterium tuberculosis MabA (FabG1) inhibitors through a fragment-based screening. doi:10.1016/j.ejmech.2020.112440 names it Eur J Med Chem 2020
[Analysis on drug resistance-associated mutations of multi-drug resistant Mycobacterium tuberculosis based on whole-genome sequencing in China]. doi:10.3760/cma.j.cn112338-20191111-00800 Zhonghua Liu Xing Bing Xue Za Zhi 2020
Epidemiological cut-offs for Sensititre susceptibility testing of Mycobacterium tuberculosis: interpretive criteria cross validated with whole genome sequencing. doi:10.1038/s41598-020-57992-x Sci Rep 2020
WGS more accurately predicts susceptibility of Mycobacterium tuberculosis to first-line drugs than phenotypic testing. doi:10.1093/jac/dkz215 J Antimicrob Chemother 2019
Use of whole-genome sequencing to predict Mycobacterium tuberculosis drug resistance in Indonesia. doi:10.1016/j.jgar.2018.08.018 J Glob Antimicrob Resist 2019
New epidemic cluster of pre-extensively drug resistant isolates of Mycobacterium tuberculosis Ural family emerging in Eastern Europe. doi:10.1186/s12864-018-5162-3 BMC Genomics 2018
Significance of Coexisting Mutations on Determination of the Degree of Isoniazid Resistance in Mycobacterium tuberculosis Strains. doi:10.1089/mdr.2017.0330 Microb Drug Resist 2018
Whole genome sequencing to complement tuberculosis drug resistance surveys in Uganda. doi:10.1016/j.meegid.2016.02.019 Infect Genet Evol 2016
Novel katG mutations causing isoniazid resistance in clinical M. tuberculosis isolates. doi:10.1038/emi.2015.42 Emerg Microbes Infect 2015
Epidemiologic Correlates of Pyrazinamide-Resistant Mycobacterium tuberculosis in New York City. doi:10.1128/AAC.00764-15 Antimicrob Agents Chemother 2015
MUBII-TB-DB: a database of mutations associated with antibiotic resistance in Mycobacterium tuberculosis. doi:10.1186/1471-2105-15-107 BMC Bioinformatics 2014
Clonal expansion of Mycobacterium tuberculosis isolates and coexisting drug resistance in patients newly diagnosed with pulmonary tuberculosis in Hanoi, Vietnam. doi:10.1186/1756-0500-6-444 BMC Res Notes 2013
Downregulation of katG expression is associated with isoniazid resistance in Mycobacterium tuberculosis. doi:10.1111/j.1365-2958.2011.07547.x Mol Microbiol 2011
Unequal distribution of resistance-conferring mutations among Mycobacterium tuberculosis and Mycobacterium africanum strains from Ghana. doi:10.1016/j.ijmm.2010.04.019 Int J Med Microbiol 2010
Physiological function of mycobacterial mtFabD, an essential malonyl-CoA:AcpM transacylase of type 2 fatty acid synthase FASII, in yeast mct1Delta cells. doi:10.1155/2009/836172 Comp Funct Genomics 2009
The essential mycobacterial genes, fabG1 and fabG4, encode 3-oxoacyl-thioester reductases that are functional in yeast mitochondrial fatty acid synthase type 2. doi:10.1007/s00438-009-0474-2 names it Mol Genet Genomics 2009
Rolling circle amplification and multiplex allele-specific PCR for rapid detection of katG and inhA gene mutations in Mycobacterium tuberculosis. doi:10.1016/j.ijmm.2009.05.006 Int J Med Microbiol 2009
Molecular analysis of isoniazid resistance in different genotypes of Mycobacterium tuberculosis isolates from Iran. doi:10.1089/mdr.2008.0842 Microb Drug Resist 2008
Mass-spectrometry based minisequencing method for the rapid detection of drug resistance in Mycobacterium tuberculosis. doi:10.1016/j.mimet.2007.05.015 J Microbiol Methods 2007
Molecular characteristics of rifampicin- and isoniazid-resistant Mycobacterium tuberculosis isolates from the Russian Federation. doi:10.1093/jac/dkm086 J Antimicrob Chemother 2007
Functional complementation of the essential gene fabG1 of Mycobacterium tuberculosis by Mycobacterium smegmatis fabG but not Escherichia coli fabG. doi:10.1128/JB.01740-06 names it J Bacteriol 2007
Detection of multidrug resistance in Mycobacterium tuberculosis. doi:10.1128/JCM.00750-06 J Clin Microbiol 2007
Molecular characterization of isoniazid-resistant Mycobacterium tuberculosis isolates collected in Australia. doi:10.1128/AAC.49.10.4068-4074.2005 Antimicrob Agents Chemother 2005
Crystal structure of MabA from Mycobacterium tuberculosis, a reductase involved in long-chain fatty acid biosynthesis. doi:10.1016/S0022-2836(02)00463-1 J Mol Biol 2002
MabA (FabG1), a Mycobacterium tuberculosis protein involved in the long-chain fatty acid elongation system FAS-II. doi:10.1099/00221287-148-4-951 names it Microbiology (Reading) 2002

Title+abstract index only: a paper that names this gene solely in its body text, a figure legend or a supplement is invisible here. That is why this list sits beside the curated layer rather than replacing it - Rv0007's characterisation, found by a full-text sweep, returns zero in this one. Absence from this list is not absence from the literature. Source: PubMed E-utilities sweep (esearch + esummary), every alias of the gene searched in conjunction with a mycobacterial context term; ambiguous common-word aliases excluded. phase198, 2026-09-06.

This layer CITES the literature and adds context; it does not change the verdict or the function stated elsewhere in this fiche. This distinguishes a gene that is dark because nobody has looked from one that is dark despite having been studied. Source: PubMed (whole): H37Rv locus tag + GENE NAME + ortholog identifiers (Mb…, MMAR_…, MSMEG_…, ML…, MAB_…), under a mycobacterial context filter; hits verified against the abstract text. Species-context counts distinguish M. tuberculosis literature from literature on other mycobacteria. phase76/phase77, 2026-07-13.

Post-translational modifications

4 reported modified residue(s), incl. 3 phosphosite(s): N-acetylthreonine @2, Phosphothreonine @21, Phosphothreonine @114, Phosphothreonine @191.

Experimentally reported post-translational modification(s). A phosphosite indicates the protein is expressed and is a substrate of the M. tuberculosis Ser/Thr/Tyr kinase signalling network — a regulatory context, NOT a molecular function. Source: UniProt (Modified residue features; PTM sites curated from the M. tuberculosis literature).

CRISPRi vulnerability

Vulnerability index -11.07 (95% CI -12.70 to -9.12). A more negative index = more vulnerable to knockdown (better drug-target quality); indicative threshold VI ≤ -6 = highly vulnerable.

Quantitative CRISPRi knockdown, graded (finer than binary Tn-seq essentiality). Source: CRISPRi vulnerability index (Bosch 2021, supplementary Table S2 'mmc3.xlsx', bulk import via Europe PMC -- supersedes the per-gene pebble.rockefeller.edu scrape of phase46_crispri_vulnerability.py).

Legacy record & comparison (Mycobrowser)

Mycobrowser functionInvolved in the fatty acid biosynthesis pathway (first reduction step) (mycolic acid biosynthesis); reduces KASA/KASB products [catalytic activity: (3R)-3-hydroxyacyl-[acyl-carrier protein] + NADP+ = 3-oxoacyl-[acyl-carrier protein] + NADPH].
Mycobrowser EC 1.1.1.100 · agrees with the atlas

The legacy Mycobrowser record is shown for verification. Mycobrowser is no longer maintained; its EC numbers predate recent nomenclature revisions, so a class change usually reflects re-numbering, not a conflict.

Orthologues (reciprocal best hits across mycobacteria)

M. bovis Mb1519 · 100.0% identity
M. leprae ML1807c · 69.7% identity
M. marinum MMAR_2289 · 92.3% identity
M. smegmatis MSMEG_3150 · 85.6% identity
M. orygis RJtmp_001566 · 99.6% identity
M. abscessus MAB_2723c · 69.8% identity

Reciprocal-best-hit orthologues (DIAMOND) against the Mycobrowser reference proteomes. A missing species is informative: e.g. a gene absent from M. leprae was likely lost in its reductive genome evolution. Locus tags link to Mycobrowser.

Curated reference (UniProt)

UniProt P9WGT3 SwissProt · reviewed · Evidence at protein level
UniProt name3-oxoacyl-[acyl-carrier-protein] reductase MabA
EC (curated) EC 1.1.1.100, EC 1.1.1.36
Curated functionPart of the mycobacterial fatty acid elongation system FAS-II, which is involved in mycolic acid biosynthesis. Catalyzes the NADPH-dependent reduction of beta-ketoacyl derivatives, the second step of the FAS-II elongation cycle. May preferentially metabolize long-chain substrates (C8-C20). Can use CoA derivatives as substrates in vitro.

Functional vocabulary (eggNOG-mapper, orthology transfer)

COG category I Lipid transport and metabolism
Q Secondary metabolites biosynthesis, transport and catabolism
Preferred namefabG1
eggNOG descriptionreductase
Orthologous groupCOG1028
EC number EC 1.1.1.100
KEGG orthology K00059, K11610
KEGG pathways map00061, map00333, map00780, map01040, map01100, map01130, map01212
KEGG modules M00083, M00572
Gene Ontology (70) GO:0000166, GO:0003674, GO:0003824, GO:0004312, GO:0004316, GO:0005488, GO:0005575, GO:0005623, GO:0005886, GO:0006082, GO:0006629, GO:0006631 +58 more

Orthology-based transfer (eggNOG 5.0.2, diamond). EC/KO/GO/CAZy are computed annotations, not manual curation; cross-check against the primary literature before treating a specific reaction as established.

Conservation & selection (intra-MTBC, 142 601 strains, snapshot of 2026-09-29)

pN/pS 0.07 · quasi-invariant (6 sites), pN/pS underpowered
Polymorphic sites (≥ 0.1% of strains) 5 synonymous, 1 missense, 0 nonsense, 0 frameshift

pN/pS from segregating SNPs (singletons removed) normalised by possible sites. Low pN/pS = purifying selection (a strong signal that a "hypothetical" is a real, constrained gene). A high pN/pS is ambiguous: relaxed constraint or positive selection (drug resistance, antigenic variation) inflate it; e.g. rpoB/katG/pncA score high here for resistance, not loss of function. A clonal disruption (one allele over a clade) suggests lineage pseudogenisation; a convergent one (many independent alleles) is typical of resistance loss-of-function.

Outgroup conservation (beyond the MTBC) Bacteria

Genus-wide presence (~53 non-MTBC Mycobacterium) present in 53/53 (100%) · mean identity 86.8% · 4/4 closest MTBAP relatives
conserved across the genus (present in 53/53 non-MTBC Mycobacterium genomes, incl. distant relatives) — an ancient core gene predating the genus radiation
Phylostratum (deepest detected homolog) MTBC-specific → Mycobacterium → Mycobacteriaceae → Corynebacteriales → Actinomycetia → Bacteria
detected in 11/13 non-Mycobacterium reference genomes (down to Bacteria) · mean identity 58.3%
detected down to outside the phylum (Proteobacteria/Firmicutes controls) — a universally conserved, ancient bacterial gene

Two orthogonal outgroup signals. M. canettii (the immediate outgroup) gives a deep-divergence dN/dS (a low value confirms a constrained, real gene; shown as confident only at ≥8 substitutions, else flagged low-power). Genus-wide presence/absence (tblastn vs assembled non-MTBC genomes) places the gene on the ancient-core ↔ MTBC-specific axis: a gene absent even from the closest MTBAP relatives is a candidate MTBC-specific innovation (possible host-adaptation factor, to confirm by synteny). The phylostratum extends that axis outside the genus (tblastn vs 13 reference genomes spanning Mycobacteriaceae → Corynebacteriales → Actinomycetia → outside the phylum): it is the deepest clade in which a homolog is still detected, i.e. a proxy for gene age. Read it with the null model in mind: a shallow (young) stratum can also reflect homology-detection failure for short or fast-evolving ORFs, so it is a descriptive axis, not a proof of novelty.

Essentiality (transposon mutagenesis) essential

DeJesus 2017 callES · essential
What the call meansessential: insertions absent across the whole ORF
TA sites (Himar1) 13 in the ORF — 13 in the essential state, 0 growth-defect, 0 non-essential, 0 growth-advantage. Saturation 0.077, mean read count 1. A region of the protein devoid of TA sites is invisible to this assay: nothing can be inferred about it, in either direction.
All 13 sites lie in this ORF alone (no overlapping CDS shares any), so the call is attributable to this gene.

Genome-wide Himar1 transposon essentiality in H37Rv (DeJesus 2017). An essential call (ES/ESD/GD) is strong, independent evidence that a "hypothetical" locus encodes a functional, selectively required gene — orthogonal to intra-species conservation.

Drug resistance (WHO catalogue) isoniazidethionamide

isoniazid4 catalogued resistance-associated variant(s)
ethionamide2 catalogued resistance-associated variant(s)

This gene carries mutations classed Associated with resistance (WHO grade 1–2) in the consolidated catalogue (WHO 2nd ed. 2023 + tb-profiler). Only the R-associated tier is shown; "uncertain" and empirical-only signals are excluded. Test a specific strain or variant with the resistance tester. Research context, not a clinical diagnostic.

Proteomics (mass spectrometry) detected

MS detectiondetected in 12 of 16 independent MS datasets
Integrated abundance492.0 ppm · rank 414/3519 (88.3th percentile)

Detection by mass spectrometry is direct, experimental evidence that the protein product exists — orthogonal to sequence conservation and to Tn-seq essentiality, and especially decisive for a "hypothetical" locus. Read the dataset count as abundance, not as replication. Measured across this atlas (3,491 detected proteins), the number of datasets a protein appears in tracks its abundance almost monotonically: median 1.2 ppm at 1 dataset of 16, 27 ppm at 10, 392 ppm at 15, 1,325 ppm at 16 — three orders of magnitude. A high count therefore says the protein is abundant more than it says several independent experiments confirmed it. What the count does establish, at any value, is that the product exists.

Predicted localisation (DeepTMHMM + lipobox) no export signal, no TM helix

Predictionno signal peptide, no TM helix (DeepTMHMM class GLOB)
DeepTMHMM classGLOB

A verified absence of signals, which is not a compartment. No Sec/Tat signal peptide, no transmembrane helix and no lipobox were found on this sequence. The predictor reports topology and export signals; it does not measure where the protein ends up, so this page draws no cytoplasmic conclusion from it. In M. tuberculosis that reservation is not theoretical: the 12 Esx paralogues of this atlas — EsxA/ESAT-6 and EsxB/CFP-10 among them, the best-established secreted proteins of the species — carry this very call, because substrates of the type VII (ESX) secretion system leave no recognisable signal. « Secreted » and « no signal peptide » are true together here.

Transmembrane topology and signal peptide from DeepTMHMM (deep-learning reference predictor); lipoproteins from a (myco)bacterial lipobox motif. A sequence-based prediction of subcellular context.

Physico-chemical properties (computed, ProtParam)

Length247 aa
Molecular weight25.7 kDa
Theoretical pI8.76
GRAVY0.036 (hydrophobic)
Aliphatic index83.4
Aromaticity0.057
Instability index26.9 (stable)

Computed from the ancestral MTBC0 sequence with the ExPASy ProtParam method (Biopython). Descriptive biophysical context: a positive GRAVY flags a hydrophobic (often membrane) protein, a high instability index (>40) predicts a short in-vitro half-life, an extreme pI hints at compartment or binding partner.

Domains (Pfam, hmmscan --cut_ga)

PfamAccessioni-EvalueResiduesDescription
adh_shortPF00106.32 4.3e-4917–196 short chain dehydrogenase
EpimerasePF01370.28 6.7e-0918–142 NAD dependent epimerase/dehydratase family
adh_short_C2PF13561.13 7.4e-5624–243 Enoyl-(Acyl carrier protein) reductase
KRPF08659.17 8.7e-1658–169 KR domain

3D structure (interactive — Mol*/pdbe-molstar)

Experimental structure 1uzm (PDBe), the strongest available structural evidence for this gene. Drag to rotate, scroll to zoom; hetero-groups (ligands, ions, waters hidden by default) shown as sticks.

Experimental structures (Protein Data Bank) 4 solved

PDBMethodResolutionCoverage
1uzm X-ray diffraction 1.49 Å 100%
1uzn X-ray diffraction 1.91 Å 100%
1uzl X-ray diffraction 2.0 Å 100%
2ntn X-ray diffraction 2.3 Å 100%

Experimentally solved structures mapped from the UniProt accession via PDBe/SIFTS (4 total; up to 8 shown, ranked by sequence coverage then resolution). An experimental structure is direct proof of the folded product and the strongest structural evidence — superseding the predicted ESMFold/AlphaFold models below for any covered region.

Structural search (AlphaFold DB model, Foldseek vs PDB — genome-wide) pLDDT 95.8

PDB hitprobTM (aln)TM (query)TM (target)Seq. id.Cov. q / tE-valueDescription
1uzn-assembly1_A-2 1.00 1.00 0.97 1.00 99% 97% / 100% 4.7e-47 sig 1uzn-assembly1_A-2 MabA from Mycobacterium tuberculosis
1uzn-assembly1_B-2 1.00 0.99 0.91 0.99 93% 97% / 100% 3.4e-44 sig 1uzn-assembly1_B-2 MabA from Mycobacterium tuberculosis
1uzl-assembly1_B-2 1.00 0.99 0.91 0.99 94% 97% / 100% 9.9e-43 sig 1uzl-assembly1_B-2 MabA from Mycobacterium tuberculosis
5ovj-assembly1_A 1.00 0.98 0.95 0.98 86% 97% / 100% 5.0e-43 sig 5ovj-assembly1_A Structure of the apo form of Mycobacterium smegmatis MabA
5ovl-assembly1_C 1.00 0.98 0.93 0.98 83% 97% / 100% 1.1e-41 sig 5ovl-assembly1_C crystal structure of MabA bound to NADP+ from M. smegmatis

Foldseek search of the AlphaFold DB model (mean pLDDT 95.8, gated at 70) against the PDB — a genome-wide extension of the ESMFold dark-gene search that also covers proteins beyond the single-sequence length limit. Confident structural neighbours (E < 0.01) shown.

Genomic context (neighbours & predicted operon) operon of 3

Upstream (5' on genome)Rv1482c (- strand, 140 bp gap)
Downstream (3' on genome)inhA (+ strand, 18 bp gap)
Predicted operon fabG1 · inhA · hemZ

Neighbours from the H37Rv annotation (+ strand). The operon is predicted by co-directional intergenic distance (same strand, gaps ≤50 bp) — a transcription-unit hypothesis, not a mapped TSS. For a "hypothetical", co-transcription with a characterised operon is a concrete functional lead (complements the STRING neighborhood channel below).

Published operon evidence (two independent sources)

Roback 2007 (logistic regression: distance + expression correlation, 474 microarrays) operon of 3: fabG1 · inhA · hemZ — agrees with the distance heuristic above
REMap 2016 (RNA-seq coverage continuity, CDC1551, tag MT1530) exponential phase: operon of 3, Rv1483 · Rv1484 · Rv1485 (coverage 62.69)
stationary phase: operon of 2, Rv1483 · Rv1484 (coverage 27.08) — agrees with the distance heuristic above

Two independent published operon maps, cited alongside the distance heuristic above: an association corroborating or contradicting the heuristic, never proof of shared function. REMap's RNA-seq coverage continuity is the most direct of the three signals; Roback's logistic regression and the intergenic-distance heuristic are statistical proxies.

Transcriptional regulation (signed TRN: ChIP-seq + TFOE)

Regulated by (1 TF) Rv1353c (represses)

Regulatory edges from the ISB signed transcriptional regulatory network (TF ChIP-seq binding, Minch 2015 + TF-overexpression response, Rustad 2014). An edge is regulatory evidence (binding and/or expression change), not necessarily direct. For a "hypothetical", membership in a known regulon (e.g. DosR dormancy, PhoP virulence) is a physiological-context lead, not a function.

Condition: Condition-blind by construction. These edges come from transcription-factor OVEREXPRESSION in a single laboratory condition, so a listed regulator is not a claim that it governs this gene in every circumstance. Measured counter-examples exist within this atlas (see Rv2516c, where the DosR regulon collapses under moxifloxacin while the gene itself rises). Read a regulator as 'capable of shifting this gene', and look for the condition before building a hypothesis on it.

Additional regulons (curated, outside the TFOE-derived TRN)

crp binding site only -- direction not determined (low confidence · CRP regulon (Kahramanoglou et al. 2014))
ChIP-seq : site de fixation CRP (1 des 191 sites de Kahramanoglou et al. 2014) ; aucun changement d'expression rapporte pour ce gene chez le mutant delta-crp
Caveat: Site de fixation CRP mesure par ChIP-seq (Kahramanoglou et al. 2014), SANS changement d'expression mesure pour ce gene chez le mutant delta-crp : le sens de la regulation n'est PAS determine. Ecrire « site de fixation CRP en amont », jamais « regule par CRP ». L'article ne distingue pas « non differentiellement exprime » de « sous le seuil », donc l'absence de ce gene de la table d'expression n'est pas une preuve de non-regulation. Pic divergent entre Rv1483 et Rv1482c : l'article ne tranche pas lequel des deux genes flanquants est la cible reelle. Les deux loci sont verses avec cette meme reserve.

Curated from primary literature not covered by the ISB signed TRN (Minch 2015 / Rustad 2014): Zur regulon (Maciag et al. 2007, PMID 17098899), SigG regulon (Gaudion et al. 2013, PMID 23871545), LexA/SOS regulon (Smollett et al. 2012, PMID 22528497) — added P16.25 (2026-08-18); CRP regulon (Kahramanoglou et al. 2014, PMID 24957601) — added P16.25b (2026-09-27). Confidence and caveats are per-edge and carried from the source paper — read them before citing a specific gene as "regulated by" its listed TF. An entry reading "binding site only — direction not determined" is not a regulation claim: it records a measured ChIP-seq binding site for which the source reports no expression change, and the absence of such a change is not evidence of absent regulation.

Functional interaction network (STRING v12, guilt-by-association)

Explore full network →

Node colour = verdict, dashed = still uncharacterised; edge colour = evidence (green experimental, orange genomic-context, grey co-expression), width ∝ score. Click a partner to open its page; "Explore full network" to walk the graph.

Closest characterised functional partner: inhA (NADH-dependent enoyl-[ACP), high confidence (score 976, all STRING channels except text-mining; the partner is chosen on its genomic-context evidence).

Showing the 15 strongest of this gene's 135 partners at medium confidence (20 at high confidence). The table is an extract, not a neighbourhood: across the proteome the real median degree is 34 while the served median is 15, so no hub, degree distribution or centrality may be read on this table. None of the 135 partners rests on an interaction measured in M. tuberculosis itself.

PartnerProductScoreNo text-miningChannels (≥400)
Rv1484 inhA NADH-dependent enoyl-[ACP 997 976 ctx neighborhood:857 coexpression:785 textmining:883
Rv1485 hemZ ferrochelatase 879 862 ctx neighborhood:857
Rv2243 fabD malonyl CoA-acyl carrier protein transacylase 901 841 ctx cooccurence:716 textmining:407
Rv0951 sucC succinyl-CoA ligase subunit beta 833 826 coexpression:805
Rv2524c fas exp (transferred) fatty acid synthase 857 802 coexpression:509 experimental:475
Rv2246 kasB 3-oxoacyl-ACP synthase 2 913 794 ctx cooccurence:658 textmining:598
Rv2245 kasA 3-oxoacyl-ACP synthase 1 947 792 ctx cooccurence:655 textmining:759
Rv0533c fabH 3-oxoacyl-ACP synthase III 872 637 ctx cooccurence:570 textmining:665
Rv0635 hadA (3R)-hydroxyacyl-ACP dehydratase subunit HadA 648 590
Rv1482c hypothetical protein 841 589 ctx neighborhood:587 textmining:630
Rv1479 moxR1 transcriptional regulator MoxR1 557 557 ctx neighborhood:544
Rv1480 hypothetical protein 550 551 ctx neighborhood:544
Rv1481 membrane protein 548 548 ctx neighborhood:544
Rv1937 oxygenase 593 546
Rv0547c oxidoreductase 561 545 ctx cooccurence:478

STRING combines evidence channels (neighborhood, fusion, cooccurrence, coexpression, experimental, database, text-mining) into a 0–1000 score. The ctx badge marks edges carried by the genomic-context channels (conserved neighborhood, fusion, phylogenetic co-occurrence), which are independent of orthology and structure and the strongest signal for an unknown gene. The no text-mining column recomputes the score from data alone, so a link that does not depend on the literature is visible. Association is a function hypothesis, not proof: corroborate with the operon context and the primary literature before assigning a function.

Where the experimental evidence comes from, and why it matters here. STRING's experimental channel fuses interactions measured in M. tuberculosis with interactions measured in another organism and transferred to this pair by orthology. The two are not equivalent for this atlas, whose standing rule is that better studied elsewhere is not a function established in M. tuberculosis. Measured on the served network: of the 38 229 partner pairs shown across the atlas, 13 483 partner rows carry a non-zero experimental channel, and only 106 pairs rest on an interaction measured in M. tuberculosis itself — 0.3 % of the network. Those 106 are long-established complexes (ESX-1/ESAT-6, RNA polymerase with CarD and RbpA, the Pup–Mpa proteasome, gyrase, Emb, GarA with PknB and PknG, the Rel modules); no still-uncharacterised gene is among them. The reason is not a gap in this atlas but in the literature: there is almost no experimental interactome of this bacterium, IntAct holding 134 curated protein pairs for a ~4 000-gene proteome. A exp (transferred) badge is therefore a lead, never a measurement, and an absence of badge is not evidence that the pair does not interact.

Evidence

  • Legacy H37Rv annotation: 3-oxoacyl-ACP reductase FabG
  • MTBC0 PGAP product: 3-oxoacyl-ACP reductase FabG1
  • Pfam (hmmscan --cut_ga): adh_short PF00106.32 (E=4e-49), Epimerase PF01370.28 (E=7e-09), adh_short_C2 PF13561.13 (E=7e-56), KR PF08659.17 (E=9e-16)
  • (auto-curated by rules from PGAP + Pfam + Foldseek; not hand-reviewed)

Sources

  • Ancestral sequence & coordinates: Harrison LB et al. (2024), An imputed ancestral reference genome for the MTBC, doi:10.1101/2023.09.07.556366
  • Product annotation: NCBI PGAP on MTBC0; legacy from H37Rv NC_000962.3 (RefSeq NP_215999.1)
  • Domains: Pfam-A via hmmscan --cut_ga — adh_short (PF00106.32), Epimerase (PF01370.28), adh_short_C2 (PF13561.13), KR (PF08659.17)
  • Sequence-level signal: ESM Atlas (EvolutionaryScale × BioHub) — exploratory
  • Controlled vocabulary: eggNOG-mapper 2.1.12 (Cantalapiedra et al. 2021, doi:10.1093/molbev/msab293), eggNOG 5.0 DB (Huerta-Cepas et al. 2019) — OG COG1028
  • Curated reference: UniProt P9WGT3 (SwissProt, reviewed; Evidence at protein level)
  • Intra-MTBC selection: pN/pS and disruption from SPDI variants of 142 601 MTBC strains (this work, local collection vs H37Rv NC_000962.3)
  • Genome-wide structure: AlphaFold DB model (Jumper et al. 2021, doi:10.1038/s41586-021-03819-2; Varadi et al. 2024, doi:10.1093/nar/gkad1011) searched vs PDB with Foldseek (mean pLDDT 95.8)
  • Interaction network: STRING v12.0 (Szklarczyk et al. 2023, doi:10.1093/nar/gkac1000), taxon 83332, CC-BY 4.0 — 135 functional partner(s); context anchor inhA
  • Essentiality: genome-wide transposon mutagenesis in H37Rv — DeJesus et al. 2017 (mBio, doi:10.1128/mBio.02133-16, CC BY)
  • Proteomics: integrated mass-spectrometry abundance from PaxDb 5.0 (Huang et al. 2023, doi:10.1016/j.mcpro.2023.100640), taxon 83332 — weighted average of 16 datasets, incl. Schubert et al. 2013 (doi:10.1016/j.chom.2013.04.008) and Albrethsen et al. 2013 (doi:10.1074/mcp.M112.018846)
  • Functional category: TubercuList scheme (Cole et al. 1998, doi:10.1038/31159), via Mycobrowser (Kapopoulou et al. 2011, doi:10.1016/j.tube.2010.09.006)
  • Orthologues: reciprocal best hits (DIAMOND, Buchfink et al. 2021, doi:10.1038/s41592-021-01101-x) against Mycobrowser release 5 reference proteomes
  • Experimental structures: PDBe/SIFTS UniProt→PDB mapping (Dana et al. 2019, doi:10.1093/nar/gky1114)
  • Genomic context / operon: H37Rv annotation; operon predicted by co-directional intergenic distance (Salgado et al. 2000, doi:10.1073/pnas.030539397)
  • Transcriptional regulation: ISB signed TRN — TF ChIP-seq (Minch et al. 2015, doi:10.1038/ncomms6829) + TF overexpression (Rustad et al. 2014, doi:10.1186/gb-2014-15-11-502)
  • Drug resistance: consolidated catalogue, WHO 2nd ed. 2023 (9789240082410) + tb-profiler; only the resistance-associated tier (grade 1–2) is surfaced
  • Physico-chemical properties: ExPASy ProtParam method via Biopython (Gasteiger et al. 2005), computed from the MTBC0 sequence
  • Predicted localisation: DeepTMHMM (Hallgren et al. 2022, doi:10.1101/2022.04.08.487609) for transmembrane topology and signal peptide
  • Primary literature: none located yet; annotation rests on the domain/homology sources above.

Ancestral MTBC0 protein sequence

>mtbc0_001586|Rv1483|fabG1
MTATATEGAKPPFVSRSVLVTGGNRGIGLAIAQRLAADGHKVAVTHRGSGAPKGLFGVECDVTDSDAVDRAFTAVEEHQGPVEVLVSNAGLSADAFLMRMTEEKFEKVINANLTGAFRVAQRASRSMQRNKFGRMIFIGSVSGSWGIGNQANYAASKAGVIGMARSIARELSKANVTANVVAPGYIDTDMTRALDERIQQGALQFIPAKRVGTPAEVAGVVSFLASEDASYISGAVIPVDGGMGMGH